L Savi

513 total citations
23 papers, 286 citations indexed

About

L Savi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Physiology. According to data from OpenAlex, L Savi has authored 23 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 4 papers in Physiology. Recurrent topics in L Savi's work include Blood Pressure and Hypertension Studies (6 papers), Chemokine receptors and signaling (3 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). L Savi is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Chemokine receptors and signaling (3 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). L Savi collaborates with scholars based in Italy, United States and Japan. L Savi's co-authors include M. M. Mariani, Marco Mettimano, Alessio Migneco, Marcello Candelli, Antonio Gasbarrini, Veronica Ojetti, Francesco Franceschi, Paolo Pola, Dario Arzani and Carmine Cardillo and has published in prestigious journals such as Diabetologia, Critical Care and Clinica Chimica Acta.

In The Last Decade

L Savi

20 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Savi Italy 8 101 74 47 45 40 23 286
Lars Gullestad Norway 8 71 0.7× 166 2.2× 40 0.9× 28 0.6× 41 1.0× 14 330
İlker Kiriş Türkiye 12 78 0.8× 75 1.0× 32 0.7× 22 0.5× 16 0.4× 23 284
Sumiyo Yamashita Japan 12 63 0.6× 189 2.6× 55 1.2× 35 0.8× 41 1.0× 36 364
Sawako Goto Japan 9 65 0.6× 47 0.6× 32 0.7× 32 0.7× 21 0.5× 22 376
Andrea Leonardo Cecchini Italy 13 153 1.5× 48 0.6× 41 0.9× 57 1.3× 55 1.4× 23 349
Ethel Kouba United States 5 86 0.9× 75 1.0× 68 1.4× 22 0.5× 45 1.1× 5 281
R. Ruggier United Kingdom 9 116 1.1× 29 0.4× 34 0.7× 49 1.1× 24 0.6× 17 381
Luis C. Ramirez United States 9 84 0.8× 127 1.7× 51 1.1× 23 0.5× 196 4.9× 13 416
Rozh H. Al‐Mashhadi Denmark 9 54 0.5× 70 0.9× 45 1.0× 28 0.6× 23 0.6× 18 256
Jordi Bozzo Spain 10 33 0.3× 40 0.5× 90 1.9× 21 0.5× 13 0.3× 17 313

Countries citing papers authored by L Savi

Since Specialization
Citations

This map shows the geographic impact of L Savi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Savi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Savi more than expected).

Fields of papers citing papers by L Savi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Savi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Savi. The network helps show where L Savi may publish in the future.

Co-authorship network of co-authors of L Savi

This figure shows the co-authorship network connecting the top 25 collaborators of L Savi. A scholar is included among the top collaborators of L Savi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Savi. L Savi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stasio, Enrico Di, Andrea Russo, Marco Mettimano, et al.. (2011). NT-proBNP: A marker of preclinical cardiac damage in arterial hypertension. Clinica Chimica Acta. 412(11-12). 1106–1111. 6 indexed citations
2.
Giuliani, Alessandro, et al.. (2010). An Uncommon Case of Systemic Mucormycosis Associated with Spinal Cord Infarction in a Recently Diagnosed Diabetic. International Journal of Immunopathology and Pharmacology. 23(1). 355–358. 8 indexed citations
3.
Mettimano, Marco, Maria Lucia Specchia, Giuseppe La Torre, et al.. (2006). Blood Pressure Regulation by CCR Genes. Clinical and Experimental Hypertension. 28(7). 611–618. 6 indexed citations
4.
Rainero, Innocenzo, Chiara Rivoiro, Salvatore Gallone, et al.. (2005). Lack of Association between the 3092 T°C Clock Gene Polymorphism and Cluster Headache. Cephalalgia. 25(11). 1078–1081. 24 indexed citations
5.
Teixeira, Cassiano, Sandra Maria Gonçalves Vieira, L Savi, et al.. (2005). Central venous saturation as a weaning success predictor. Critical Care. 9(Suppl 1). P48–P48. 1 indexed citations
6.
Migneco, Alessio, Veronica Ojetti, Antonino De Lorenzo, Nicolò Gentiloni Silveri, & L Savi. (2005). Hypertensive crises: diagnosis and management in the emergency room.. PubMed. 8(4). 143–52. 10 indexed citations
7.
Migneco, Alessio, Veronica Ojetti, Francesco Franceschi, et al.. (2003). Eradication of Helicobacter pylori Infection Improves Blood Pressure Values in Patients Affected by Hypertension. Helicobacter. 8(6). 585–589. 59 indexed citations
8.
Mettimano, Marco, Maria Lucia Specchia, Dario Arzani, et al.. (2003). CCR5 and CCR2 gene polymorphisms in hypertensive patients. British Journal of Biomedical Science. 60(1). 19–21. 18 indexed citations
9.
Mettimano, Marco, et al.. (2000). COMBINATION THERAPY WITH BETA‐ADRENERGIC BLOCKADE AND AMLODIPINE AS SECOND LINE TREATMENT IN ESSENTIAL HYPERTENSION. International Journal of Clinical Practice. 54(7). 424–428. 5 indexed citations
10.
Mettimano, Marco, et al.. (2000). Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension.. PubMed. 1(8). 532–5. 23 indexed citations
11.
Savi, L, et al.. (1992). Sublingual nicardipine versus nifedipine to treat hypertensive urgencies.. PubMed. 30(2). 41–5. 6 indexed citations
12.
Melina, D, Lisa Capaldi, R. Di Mauro, et al.. (1990). [Sublingually administered captopril versus nifedipine in hypertension emergencies].. PubMed. 38(1-2). 37–44. 6 indexed citations
13.
Cardillo, Carmine, et al.. (1988). Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients. European Journal of Clinical Pharmacology. 34(6). 549–553. 2 indexed citations
14.
Cardillo, Carmine, L Savi, Nadia Mores, et al.. (1988). Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.. PubMed. 1(4). 281–5. 6 indexed citations
15.
Savi, L, Carmine Cardillo, & G. Bombardieri. (1985). Somatostatin and Peripheral Blood Flow in Man. Angiology. 36(8). 511–515. 4 indexed citations
16.
D'Iddio, S, et al.. (1982). L-carnitine in haemodialysed patients. Changes in lipid pattern.. PubMed. 32(3). 293–7. 4 indexed citations
18.
Pola, Paolo & L Savi. (1978). Peripheral Vascular Dynamics Studied by Calcium Ion Inhibition. Angiology. 29(7). 506–519. 3 indexed citations
19.
Pola, P., et al.. (1977). [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 81(5). 417–31. 3 indexed citations
20.
Mariani, M. M., et al.. (1971). The action of ?-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of ? receptor. Diabetologia. 7(3). 127–132. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026